Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Cancer Management and Research|August 13, 2025
Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung AdenocarcinomaJun Yamada, Naoe Jimbo, Nanami Yamasaki, et al.Japanese Journal of Clinical Oncology|February 24, 2023
Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancerHideto Ueki, Tomoaki Terakawa, Takuto Hara, et al.Anticancer Research|March 4, 2025
Genomic Profiling of Small Cell Neuroendocrine Prostate Cancer and its Implications for Targeted TherapiesJunichiro Hirata, Takuto Hara, Naoe Jimbo, et al.Internal Medicine (Tokyo, Japan)|November 12, 2019
Predominant Involvement of the Aortic Root in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Congestive Heart Failure due to Subacute Severe Aortic Regurgitation and Reversible Conduction DisturbanceAtsusuke Yatomi, Shumpei Mori, Hirotaka Kawauchi, et al.International Journal of Hematology|August 14, 2020
Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndromeKeiji Kurata, Hisayuki Matsumoto, Naoe Jimbo, et al.Pathology International|March 23, 2019
Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinomaKiyoko Koyama, Naoko Katsurada, Naoe Jimbo, et al.Genes, Chromosomes & Cancer|November 8, 2019
A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumorMasato Komatsu, Teruya Kawamoto, Maki Kanzawa, et al.Histopathology|November 17, 2017
Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancersMehmet Ozgur Avincsal, Naoe Jimbo, Kohei Fujikura, et al.Plos One|October 29, 2021
Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective studyNaoko Katsurada, Motoko Tachihara, Naoe Jimbo, et al.The Prostate|September 16, 2024
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, et al.Pageof 6